2026. Stereotactic Radiotherapy in Combination with the Immunoconjugate Trastuzumab Emtansine in Patients with HER2-Positive Oligometastatic Breast Cancer: Final Results of the Efficacy and Safety Study. Voprosy onkologii. 72, 3 (Jul. 2026), OF-2696. DOI:https://doi.org/10.37469/0507-3758-2026-72-3-OF-2696.